These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3502552)

  • 1. [Pharmacokinetics and tissue distribution of miocamycin].
    Fraschini F; Scaglione F; Cantarella G; Marchi E; Scarpazza P
    Ann Ist Super Sanita; 1987; 23(4):887-90. PubMed ID: 3502552
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of miocamycin in respiratory tract diseases].
    Rimoldi R; Fioretti M; Bandera M
    Ann Ist Super Sanita; 1987; 23(4):891-4. PubMed ID: 3502553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the efficacy and tolerability of miocamycin in the treatment of otorhinololaryngologic infection by sensitive micro-organisms].
    Bellioni P; Di Luzio Paparatti U; Salvinelli F; Artuso A
    Riv Eur Sci Med Farmacol; 1987 Sep; 9(3):293-8. PubMed ID: 3509888
    [No Abstract]   [Full Text] [Related]  

  • 4. [Miocamycin in pediatrics. Results of multicenter study in Piedmont and Valle d'Aosta].
    De Sario PN; Bianco R; De Marco A; Gavioli F; Orecchia L; Salvadori G; Stradoni P
    Ann Osp Maria Vittoria Torino; 1986; 29(7-12):317-28. PubMed ID: 3329481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of a new macrolide, miocamycin, in 150 patients with otorhinolaryngologic disorders].
    Ursino F; Grosjacques M; Panattoni G; Pardini L; Matteucci F
    Clin Ter; 1987 Jul; 122(1):13-6. PubMed ID: 2973891
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical use and evaluation of 9,3"-di-0-acetyl midecamycin (MOM) in oral surgery].
    Satoh T; Sugiura Y; Fujiwara H; Suzuki M; Takahashi K; Saigusa F; Nishida K; Hisano Y
    Shigaku; 1982 Jun; 70(1):126-36. PubMed ID: 6985345
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy using 9,3"-di-O-acetyl-midecamycin with beta-lactam antibiotics against Pseudomonas aeruginosa infection.
    Mashimo K; Homma JY; Iki Y; Inatomi K; Kasai T; Kunii O; Shimada K; Tanimoto H; Takigami T; Nishimura Y
    Jpn J Exp Med; 1981 Oct; 51(5):271-85. PubMed ID: 6798249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Miocamycin: microbiological features].
    Renzini G; Scazzocchio F; Selan L
    Ann Ist Super Sanita; 1987; 23(4):883-6. PubMed ID: 3502551
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selective spectrum antibiotic therapy and chronic bronchitis].
    Taranger J; Girbal JP; Giacchero G
    Bronches; 1974; 24(1):51-3. PubMed ID: 4419259
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of miocamycin in the acute exacerbation of chronic obstructive bronchopneumopathy. Case material contribution].
    Miravalle C; Ardizzi A; Barberis S; Galietti F; Giorgis GE; Oliaro A
    Minerva Med; 1987 May; 78(9):623-6. PubMed ID: 3495753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of miocamycin versus amoxycillin in lower respiratory tract infections in children. Clinical response and effect on natural killer activity.
    Agostoni C; Giovannini M; Fraschini F; Scaglione F; Galluzzo C; Riva E; Ferrara F
    J Int Med Res; 1988; 16(4):305-11. PubMed ID: 3262546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of dirithromycin versus miocamycin in the treatment of acute bronchitis or acute exacerbations of chronic bronchitis.
    Pozzi E
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():153-8. PubMed ID: 8478306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miokamycin penetration into oral cavity tissues and crevicular fluid.
    Fraschini F; Scaglione F; Falchi M; Manzoni P; D'Orsi S; Badile S; Pignanelli M
    Int J Clin Pharmacol Res; 1989; 9(4):293-6. PubMed ID: 2789197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with miocamycin in bacterial diseases of odontostomatological relevance].
    de Rysky S; Menghini P; Pozzoli PA
    Minerva Stomatol; 1985; 34(5):871-80. PubMed ID: 3878934
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostatic tissue concentrations and serum levels of Myocamicin in human subjects.
    Fraschini F; Scaglione F; Cicchetti F; Rossi M; Borghi C; Alfano G; Maierna G; Balsamo V; Gattei G
    Drugs Exp Clin Res; 1988; 14(4):253-5. PubMed ID: 3262495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with miocamycin in the treatment of respiratory tract infections.
    Rimoldi R; Fioretti M; Bandera M
    Drugs Exp Clin Res; 1985; 11(4):263-8. PubMed ID: 3879725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Miocamycin in ambulatory dental surgical practice].
    Capuzzi P; Mazzanti F; Balla G; Tani P
    G Stomatol Ortognatodonzia; 1986; 5(3):49-51. PubMed ID: 3499403
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic data and therapeutic efficacy of miocamycin: serum, urinary and prostatic levels. Therapeutic aspects in acute urethral syndrome and non-gonococcal urethritis.
    Furneri PM; Roccasalva L; Fallica L; Tempera G
    J Chemother; 1989 Jul; 1(4 Suppl):581-2. PubMed ID: 16312542
    [No Abstract]   [Full Text] [Related]  

  • 19. [Miocamycin in the prevention and treatment of cutaneous infections in the emergency service].
    Bertinieri G; Caser L; Ceffa G; Cortese P; Martina C; Riccardi G; Calogero G
    Minerva Med; 1987 Nov; 78(21):1625-7. PubMed ID: 3500430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Chlamydia trachomatis in chronic prostatitis: diagnostic investigation and therapeutic experience with miocamycin.
    Rossi R; Mora A
    J Chemother; 1989 Jul; 1(4 Suppl):913-5. PubMed ID: 16312701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.